Treatment of Moderate to Severe Lateral Canthal Lines

PHASE3CompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

September 25, 2020

Study Completion Date

February 10, 2021

Conditions
Lateral Canthal Lines
Interventions
BIOLOGICAL

botulinum toxin

neuromodulator

BIOLOGICAL

Placebo

placebo

Trial Locations (10)

10549

The Center for Dermatology, Cosmetic & Laser Surgery, Mount Kisco

14564

Rochester Dermatologic Surgery, Ltd, Victor

21208

Facial Plastic Surgicenter, Ltd, Baltimore

27517

Aesthetic Solutions, PA, Chapel Hill

33472

Siperstein Dermatology Group, PLLC, Boynton Beach

90266

Ablon Skin Institute and Research Center, Manhattan Beach

92075

Art of Skin, MD, Solana Beach

92121

Dermatology Cosmetic Laser Medical Associates, San Diego

V5Z 4E1

Dr. Shannon Humphrey, Inc, Vancouver

V6H-4E1

Pacific Dermaesthetics, Inc, Vancouver

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY